Low GR expression was linked to grade progression in pTa (p < 0.0001) and to nodal metastasis in pT2-4 (p = 0.0051) urothelial carcinoma of the urinary bladder and advanced pT stage (p = 0.0006) in breast carcinomas of no special type (NST), as well as to high-grade (p = 0.0066), advanced pT stage (p < 0.0001), and distant metastasis (p = 0.0081) in clear cell renal cell carcinoma. Here, NR3C1 is linked to breast carcinoma.